Cumberland Pharmaceuticals (CPIX) vs Immunic (IMUX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Cumberland Pharmaceuticals (CPIX) has outperformed Immunic (IMUX) over the past year, gaining 93.5% versus a loss of 13.3%. Over five years, CPIX leads with a +151.5% price change compared with -91.2% for IMUX. Immunic is the larger company by market cap ($104.1 million vs $103.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CPIX | IMUX |
|---|---|---|
| Share price | $6.89 | $7.63 |
| Market cap | $103.23M | $104.11M |
| 1-day change | -3.50% | -2.43% |
| YTD return | +73.12% | +42.88% |
| 1-year return | +93.54% | -13.30% |
| 5-year return | +151.46% | -91.20% |
| Forward P/E | 49.21 | — |
| EPS (TTM) | $-0.62 | $-3.83 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.28 | $17.43 |
| 52-week low | $1.85 | $5.06 |
| Distance from 52-week high | -25.75% | -56.22% |
| Average volume | 87.97K | 275.74K |
| Shares outstanding | 14.98M | 13.64M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CPIX has outperformed IMUX by 106.8 percentage points over the past year.
CPIX vs IMUX FAQ
Which is bigger, Cumberland Pharmaceuticals or Immunic?
Immunic (IMUX) is larger, with a market capitalization of $104.11M compared with $103.23M for Cumberland Pharmaceuticals (CPIX).
Which stock has performed better over the past year, CPIX or IMUX?
CPIX returned +93.54% over the past 12 months, compared with -13.30% for IMUX (price return, excluding dividends). Past performance does not predict future results.
Are Cumberland Pharmaceuticals and Immunic in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.